{"transactions":[{"id":1191009,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-03-26T21:00:10.000Z","date":"2025-03-25","kind":"sale","planned":true,"acquired":false,"shares":2347,"price":6.74,"value":15818.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted on May 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average sales price. These shares were sold in multiple transactions on March 25, 2025 at prices ranging from $6.67 to $6.79. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144923,"source":{"system":"sec-edgar","filing":"0000950170-25-045393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017025045393/ownership.xml","form_type":"4"}},{"id":1207872,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-03-13T20:30:07.000Z","date":"2025-03-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":142270,"source":{"system":"sec-edgar","filing":"0000950170-25-038796","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017025038796/ownership.xml","form_type":"4"}},{"id":1321006,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-12-27T21:31:15.000Z","date":"2024-12-26","kind":"sale","planned":true,"acquired":false,"shares":2273,"price":7.43,"value":16888.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted on May 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average sales price. These shares were sold in multiple transactions on December 26, 2024 at prices ranging from $6.98 to $7.66 The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":97270,"source":{"system":"sec-edgar","filing":"0001104659-24-132166","document":"tm2432133-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000110465924132166/tm2432133-3_4seq1.xml","form_type":"4"}},{"id":1399512,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-09-26T00:30:17.000Z","date":"2024-09-25","kind":"sale","planned":true,"acquired":false,"shares":2352,"price":5.98,"value":14064.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted on May 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average sales price. These shares were sold in multiple transactions on September 25, 2024 at prices ranging from $5.95 to $6.07. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":99543,"source":{"system":"sec-edgar","filing":"0000950170-24-109450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024109450/ownership.xml","form_type":"4"}},{"id":1610171,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-29T21:45:21.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in 48 equal monthly installments, with the first installment vesting on March 27, 2024, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":4.98,"expiration_date":"2034-02-26","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-023203","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024023203/ownership.xml","form_type":"4"}},{"id":1914950,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-24T23:31:55.000Z","date":"2023-03-14","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":101895,"source":{"system":"sec-edgar","filing":"0001209191-23-025474","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919123025474/doc4a.xml","form_type":"4/A","original_submission_date":"2023-03-17"}},{"id":1947288,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller&Acct Principal"}}],"security":"Common Shares","published_at":"2023-03-17T22:40:51.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":478430,"source":{"system":"sec-edgar","filing":"0001209191-23-019895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919123019895/doc4.xml","form_type":"4"}},{"id":2335653,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller&Acct Principal"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T22:12:07.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":524450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option grant has an exercise price of $1.71 Canadian Dollars. This represents the exercise price in United States Dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option shall vest and become exercisable on October 21, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":524450,"derivative":{"exercise_price":1.34,"expiration_date":"2027-02-09","underlying":"Subordinate Voting Shares","underlying_shares":524450},"source":{"system":"sec-edgar","filing":"0001209191-22-018614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122018614/doc4.xml","form_type":"4"}},{"id":2335652,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":81525,"kind":"person","name":"Liao Carrie","position":1,"cik":"0001899817","reported_name":"Liao Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller&Acct Principal"}}],"security":"Subordinate Voting Shares","published_at":"2022-03-14T22:12:07.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":403430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of 403,430 restricted stock units (\"RSUs\") on February 10, 2022. Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. 25% of the RSUs will vest on October 21, 2022; the remaining RSUs granted will vest with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":403430,"source":{"system":"sec-edgar","filing":"0001209191-22-018614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122018614/doc4.xml","form_type":"4"}}]}